Dr. Andrea S. Wolf has had years of experience treating patients with thoracic cancer. As the Director of the Women’s Lung Cancer Program at Mount Sinai Hospital, she also conducts research into lung cancer treatment approaches. This program encompasses clinical research, community outreach and education and a multidisciplinary approach to the treatment of lung cancer in women. Dr. Wolf is also an assistant professor of thoracic surgery at the Icahn School of Medicine at Mount Sinai located in New York, New York.
Dr. Wolf’s clinical focus is on the management of malignancies relative to the lungs, including mesothelioma, lung cancer, esophageal cancer, and mediastinal tumors. While training in Boston, Dr. Wolf developed an interest in treating mesothelioma patients and educating both her colleagues in the medical community and the public about this challenging disease state. Over the years, this interest evolved into Dr. Wolf making mesothelioma a primary focus on her career path. She has authored and co-authored several mesothelioma studies and research articles in well-respected medical journals, including one study published in The Annals of Thoracic Surgery in 2014 which showed far better survival rates in women with malignant pleural mesothelioma over men.
When asked to comment on the current standard of care for mesothelioma patients, Dr. Wolf replied, “The challenge is that there is no standard of care for mesothelioma.” Dr. Wolf’s hope is that her research will contribute to the determination of what that standard should be. When asked how she envisions the standard to progress over the next 10 years, Dr. Wolf stated, “Over the next 10 years, I anticipate progress in adjuvant therapies to prevent progression and recurrence of disease, including novel immunologic, biologic, and hormonal treatments.”
Main Speciality: Thoracic Surgery
Other Interests & Specialties: General cardiac/thoracic surgery, early stage lung cancer, pleural mesothelioma, robotic and minimally invasive techniques, video-assisted thoracic and laparoscopic surgery for benign and malignant disease of the chest wall, lung, mediastinum, diaphragm and esophagus and clinical research for treatment of lung cancers in women.
Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery, Castle Connolly Top Doctor Award
Education & Experience:
- Residency for General Surgery at Massachusetts General Hospital
- Residency in Cardiothoracic Surgery at Brigham and Women’s Hospital
- Fellowship for Thoracic Surgery at Brigham and Women’s Hospital
- Medical Degree from Harvard Medical School
Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication. Thoracic Surgery Clinic. August 2016;26(3):359-75. doi: 10.1016/j.thorsurg.2016.04.003
Women with malignant pleural mesothelioma have a threefold better survival rate than men. The Annals of Thoracic Surgery. September 2014;98(3):1020-4. doi: 10.1016/j.athoracsur.2014.04.040
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma. Disease Markers. 2015;2015. doi: 10.1155/2015/282145
Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Annals of Thoracic Surgery. February 2015;99(2):472-480. doi: 10.1016/j.athoracsur.2014.09.056
Extrapleural pneumonectomy for pleural malignancies. Thoracic Surgery Clinics. November 2014;24(4):471-475. doi: 10.1016/j.thorsurg.2014.07.014
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs